CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 71318-71472 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"DX-88 is a specific and highly active (Ki 40 pM) recombinant inhibitor of human plasma kallikrein undergoing evaluation in HAE and cardiopulmonary bypass.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T53714","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T53714","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T187","span":{"begin":0,"end":154},"obj":"Sentence"}],"attributes":[{"subj":"T187","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T544","span":{"begin":123,"end":126},"obj":"Disease"}],"attributes":[{"id":"A544","pred":"mondo_id","subj":"T544","obj":"http://purl.obolibrary.org/obo/MONDO_0019623"},{"subj":"T544","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec9d","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93a2"},{"id":"CORD-19-PD-MONDO","color":"#93bdec"}]}]}}